NO974221L - Indazolkarboksamider - Google Patents

Indazolkarboksamider

Info

Publication number: NO974221L
Authority: NO; Norway
Prior art keywords: alkyl; phenyl; naphthyl; amino; substituted
Prior art date: 1995-03-16

Application number

NO974221A

Other languages

English (en)

Other versions

NO974221D0 (no

NO312833B1 (no

Inventor

John T Catlow

Marlene Lois Cohen

Michael John Martinelli

John Mehnert Schaus

Steven P Swanson

Dennis C Thompson

Thomas Michael Wilson

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-16

Filing date

1997-09-12

Publication date

1997-10-27

1995-06-07 Priority claimed from US08/485,956 external-priority patent/US5654320A/en

1997-09-12 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1997-09-12 Publication of NO974221D0 publication Critical patent/NO974221D0/no

1997-10-27 Publication of NO974221L publication Critical patent/NO974221L/no

2002-07-08 Publication of NO312833B1 publication Critical patent/NO312833B1/no

Links

125000001624 naphthyl group Chemical group 0.000 abstract 7
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 7
125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 4
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 4
125000001475 halogen functional group Chemical group 0.000 abstract 3
239000001257 hydrogen Substances 0.000 abstract 3
229910052739 hydrogen Inorganic materials 0.000 abstract 3
125000006274 (C1-C3)alkoxy group Chemical group 0.000 abstract 2
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
-1 1-piperazinyl Chemical group 0.000 abstract 2
DITBWPUMEUDVLU-UHFFFAOYSA-N 1h-indazole-3-carboxamide Chemical class C1=CC=C2C(C(=O)N)=NNC2=C1 DITBWPUMEUDVLU-UHFFFAOYSA-N 0.000 abstract 2
125000005518 carboxamido group Chemical group 0.000 abstract 2
150000002431 hydrogen Chemical class 0.000 abstract 2
125000004356 hydroxy functional group Chemical group O* 0.000 abstract 2
125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 1
125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
108091005482 5-HT4 receptors Proteins 0.000 abstract 1
108091032151 5-hydroxytryptamine receptor family Proteins 0.000 abstract 1
102000040125 5-hydroxytryptamine receptor family Human genes 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
125000004414 alkyl thio group Chemical group 0.000 abstract 1
239000005557 antagonist Substances 0.000 abstract 1
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
125000001589 carboacyl group Chemical group 0.000 abstract 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
230000004064 dysfunction Effects 0.000 abstract 1
125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 abstract 1
125000002757 morpholinyl group Chemical group 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 abstract 1
239000004031 partial agonist Substances 0.000 abstract 1
125000004193 piperazinyl group Chemical group 0.000 abstract 1
125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Paper (AREA)
Luminescent Compositions (AREA)

NO19974221A 1995-03-16 1997-09-12 Indazolkarboksamider, fremgangsmåte for fremstilling derav, anvendelse av forbindelsene samt farmasöytiske preparaterinneholdende disse NO312833B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US40511995A	1995-03-16	1995-03-16
US08/485,956 US5654320A (en)	1995-03-16	1995-06-07	Indazolecarboxamides
PCT/US1996/003551 WO1996033713A1 (en)	1995-03-16	1996-03-14	Indazolecarboxamides

Publications (3)

Publication Number	Publication Date
NO974221D0 NO974221D0 (no)	1997-09-12
NO974221L true NO974221L (no)	1997-10-27
NO312833B1 NO312833B1 (no)	2002-07-08

Family

ID=27018928

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19974221A NO312833B1 (no)	1995-03-16	1997-09-12	Indazolkarboksamider, fremgangsmåte for fremstilling derav, anvendelse av forbindelsene samt farmasöytiske preparaterinneholdende disse

Country Status (23)

Country	Link
US (2)	US5817676A (no)
EP (1)	EP0732333B1 (no)
JP (1)	JPH11502230A (no)
CN (1)	CN1112923C (no)
AT (1)	ATE203748T1 (no)
AU (1)	AU700842B2 (no)
BR (1)	BR9608223A (no)
CA (1)	CA2215359A1 (no)
DE (1)	DE69614164T2 (no)
DK (1)	DK0732333T3 (no)
EA (1)	EA000699B1 (no)
ES (1)	ES2159345T3 (no)
GR (1)	GR3037029T3 (no)
HU (1)	HU223973B1 (no)
IL (1)	IL117438A (no)
NO (1)	NO312833B1 (no)
NZ (1)	NZ315971A (no)
PL (1)	PL183867B1 (no)
PT (1)	PT732333E (no)
RO (1)	RO119617B1 (no)
SK (1)	SK283924B6 (no)
TR (1)	TR199700956T1 (no)
WO (1)	WO1996033713A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1291569B1 (it) *	1997-04-15	1999-01-11	Angelini Ricerche Spa	Indazolammidi come agenti serotoninergici
US5914405A (en) *	1997-10-07	1999-06-22	Eli Lilly And Company	Process for preparing 3-substituted indazoles
US6069152A (en) *	1997-10-07	2000-05-30	Eli Lilly And Company	5-HT4 agonists and antagonists
ES2257869T3 (es) *	1998-08-21	2006-08-01	Novartis Ag	Nueva formulacion oral para agonistas o antagonistas de 5-ht4.
KR100413150B1 (ko)	1998-09-10	2003-12-31	에프. 호프만-라 로슈 아게	5-에이치티4 수용체 길항제로서의 디하이드로벤조디옥신 카복스아미드 및 케톤 유도체
US6743820B2 (en)	2000-07-07	2004-06-01	University Of Toledo	Methods for protection of stratified squamous epithelium against injury by noxious substances and novel agents for use therefor
CA2418904A1 (en) *	2000-08-07	2002-02-14	Laboratoire Glaxosmithkline S.A.S.	Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
EP1321142A1 (en) *	2001-12-21	2003-06-25	Novartis AG	Solid pharmaceutical composition for oral administration of Tegaserod
ATE401072T1 (de)	2002-02-12	2008-08-15	Organon Nv	1-arylsulfonyl-3-substituierte indol und indolinederivate verwendbar zur behandlung von erkrankungen des zentralnervensystem
ITMI20030287A1 (it)	2003-02-18	2004-08-19	Acraf	Indazolammidi dotate di attivita' analgesica metodo, per
ITMI20031468A1 (it) *	2003-07-18	2005-01-19	Acraf	Farmaco ativo nel dolore neuropatico
ITMI20031467A1 (it) *	2003-07-18	2005-01-19	Acraf	Farmaco attivo nel dolore neuropatico
SE0401969D0 (sv) *	2004-08-02	2004-08-02	Astrazeneca Ab	Piperidine derivatives
CA2615611C (en) *	2005-07-22	2011-09-27	Pfizer Inc.	Indazole derivatives
WO2009106980A2 (en) *	2008-02-29	2009-09-03	Pfizer Inc.	Indazole derivatives
GB201511382D0 (en)	2015-06-29	2015-08-12	Imp Innovations Ltd	Novel compounds and their use in therapy
WO2024052685A1 (en)	2022-09-09	2024-03-14	MyricX Pharma Limited	Cytotoxic imidazo[1,2-a]pyridine compounds and their use in therapy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3145215A (en) *	1961-12-19	1964-08-18	Sterling Drug Inc	Indazole derivatives
JP2795460B2 (ja) *	1988-06-20	1998-09-10	協和醗酵工業株式会社	ピラゾロアクリドン誘導体
US5017573A (en) *	1988-07-29	1991-05-21	Dainippon Pharmaceutical Co., Ltd.	Indazole-3-carboxylic acid derivatives
EP0410509A1 (en) *	1989-07-25	1991-01-30	Duphar International Research B.V	New substituted 1H-indazole-3-carboxamides
HU211081B (en) *	1990-12-18	1995-10-30	Sandoz Ag	Process for producing indole derivatives as serotonin antagonists and pharmaceutical compositions containing the same
WO1993003725A1 (en) *	1991-08-20	1993-03-04	Smithkline Beecham Plc	5-ht4 receptor antagonists
EP0603220A1 (en) *	1991-09-12	1994-06-29	Smithkline Beecham Plc	Azabicyclic compounds as 5-ht 4? receptor antagonists
JPH07507290A (ja) *	1992-05-23	1995-08-10	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	不安症の治療のための医薬
JPH07508276A (ja) *	1992-06-27	1995-09-14	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	５−ｈｔ↓４受容体アンタゴニスト含有医薬品
MX9305947A (es) *	1992-09-29	1994-06-30	Smithkline Beecham Plc	Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
TW251287B (no) *	1993-04-30	1995-07-11	Nissei Co Ltd
GB9310582D0 (en) *	1993-05-22	1993-07-07	Smithkline Beecham Plc	Pharmaceuticals

1996
- 1996-03-11 IL IL11743896A patent/IL117438A/en active IP Right Grant
- 1996-03-12 ES ES96301682T patent/ES2159345T3/es not_active Expired - Lifetime
- 1996-03-12 PT PT96301682T patent/PT732333E/pt unknown
- 1996-03-12 EP EP96301682A patent/EP0732333B1/en not_active Expired - Lifetime
- 1996-03-12 AT AT96301682T patent/ATE203748T1/de not_active IP Right Cessation
- 1996-03-12 DK DK96301682T patent/DK0732333T3/da active
- 1996-03-12 DE DE69614164T patent/DE69614164T2/de not_active Expired - Fee Related
- 1996-03-14 PL PL96322362A patent/PL183867B1/pl not_active IP Right Cessation
- 1996-03-14 JP JP8528690A patent/JPH11502230A/ja not_active Ceased
- 1996-03-14 EA EA199700242A patent/EA000699B1/ru not_active IP Right Cessation
- 1996-03-14 SK SK1242-97A patent/SK283924B6/sk unknown
- 1996-03-14 RO RO97-01719A patent/RO119617B1/ro unknown
- 1996-03-14 TR TR97/00956T patent/TR199700956T1/xx unknown
- 1996-03-14 CA CA002215359A patent/CA2215359A1/en not_active Abandoned
- 1996-03-14 BR BR9608223A patent/BR9608223A/pt not_active IP Right Cessation
- 1996-03-14 NZ NZ315971A patent/NZ315971A/xx unknown
- 1996-03-14 HU HU9801386A patent/HU223973B1/hu not_active IP Right Cessation
- 1996-03-14 CN CN96193677A patent/CN1112923C/zh not_active Expired - Fee Related
- 1996-03-14 AU AU68948/96A patent/AU700842B2/en not_active Ceased
- 1996-03-14 WO PCT/US1996/003551 patent/WO1996033713A1/en not_active Ceased
1997
- 1997-01-10 US US08/782,478 patent/US5817676A/en not_active Expired - Fee Related
- 1997-01-10 US US08/781,421 patent/US5798367A/en not_active Expired - Fee Related
- 1997-09-12 NO NO19974221A patent/NO312833B1/no unknown
2001
- 2001-10-26 GR GR20010401899T patent/GR3037029T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
RO119617B1 (ro)	2005-01-28
IL117438A0 (en)	1996-07-23
EP0732333A1 (en)	1996-09-18
PT732333E (pt)	2001-11-30
DE69614164T2 (de)	2002-04-25
AU6894896A (en)	1996-11-18
US5798367A (en)	1998-08-25
TR199700956T1 (xx)	1998-02-21
ES2159345T3 (es)	2001-10-01
AU700842B2 (en)	1999-01-14
CN1183041A (zh)	1998-05-27
US5817676A (en)	1998-10-06
JPH11502230A (ja)	1999-02-23
EP0732333B1 (en)	2001-08-01
MX9706967A (es)	1997-11-29
EA000699B1 (ru)	2000-02-28
PL322362A1 (en)	1998-01-19
PL183867B1 (pl)	2002-07-31
DK0732333T3 (da)	2001-10-08
NZ315971A (en)	1999-01-28
GR3037029T3 (en)	2002-01-31
WO1996033713A1 (en)	1996-10-31
CN1112923C (zh)	2003-07-02
HUP9801386A3 (en)	2000-03-28
NO974221D0 (no)	1997-09-12
CA2215359A1 (en)	1996-10-31
NO312833B1 (no)	2002-07-08
ATE203748T1 (de)	2001-08-15
SK283924B6 (sk)	2004-05-04
DE69614164D1 (de)	2001-09-06
SK124297A3 (en)	1998-02-04
HU223973B1 (hu)	2005-03-29
HUP9801386A2 (hu)	1999-06-28
BR9608223A (pt)	1998-12-29
EA199700242A1 (ru)	1998-04-30
IL117438A (en)	2001-12-23

Publication	Publication Date	Title
DK0732333T3 (da)	2001-10-08	Indazolcarboxamider
WO2020140005A3 (en)	2020-07-30	1 h-pyrrolo[2,3-b]pyridine derivatives and related compounds as bcl-2 inhibitors for the treatment of neoplastic and autoimmune diseases
SE0104332D0 (sv)	2001-12-19	Therapeutic agents
AR030959A1 (es)	2003-09-03	Derivados de aminoalcoholes, procedimiento para prepararlos, el uso de los mismos para preparar medicamentos y las composiciones farmaceuticas que las contienen
GB9524157D0 (en)	1996-01-24	Therapeutic agents
NZ225820A (en)	1990-09-26	Piperidyl substituted indole derivatives and pharmaceutical compositions
CO5550421A2 (es)	2005-08-31	Derivados de indol utiles para el tratamiento de enfermeda- des
NO304946B1 (no)	1999-03-08	Xantinderivat samt dets anvendelse
AP1860A (en)	2008-07-02	Aryl fused azapolycyclic compounds.
SE0104330D0 (sv)	2001-12-19	Therapeutic agents
HUP0400343A2 (hu)	2004-09-28	Ciklopropil-indol-származékok mint szelektív szerotonin-újrafelvétel inhibitorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
NZ332240A (en)	2000-07-28	Substituted indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF) and are therefor useful for treating inflammatory diseases
DK391289D0 (da)	1989-08-09	Indolderivater
AR030563A1 (es)	2003-08-27	N-[5-[[[5-alquil-2-oxazolil]metil]tio]-2-tiazolil]carboxamidas inhibidoras de cinasas dependientes de la ciclina y composiciones farmaceuticas que las contienen
PE20030332A1 (es)	2003-04-05	Terapia de combinacion para el tratamiento del cancer
NO920438L (no)	1992-08-05	N-(aryloksyalkyl)heteroaryl-8-azabicyklo(3.2.1.)oktaner, mellomprodukter og en fremgangsmaate for fremstilling deravsamt anvendelse som medikamenter
TR200200969T2 (tr)	2002-07-22	Karbonilamino türevlerinin CNS bozukluklarına karşı kullanılması
SE9904177D0 (sv)	1999-11-18	Novel compounds
HU912901D0 (en)	1992-01-28	Method for producing 3-(1h-indazole-3-yl)-4-pyridine amines and pharmaceutical preparatives containing said compounds
ES8705405A1 (es)	1987-05-16	Procedimiento de preparar nuevos derivados morfolinicos
ES2181387T3 (es)	2003-02-16	Derivados de azetidinocarboxamida para el tratamiento de trastornos del sistema nervioso central.
DK0667860T3 (da)	1999-05-25	Azaspiroalkan-derivater som terapeutiske midler